PERSEVERE in Lewy Body Dementia: A Randomized, Controlled Trial of Peer Mentor Support and Caregiver Education

坚持治疗路易体痴呆症:同伴导师支持和看护者教育的随机对照试验

基本信息

  • 批准号:
    10740652
  • 负责人:
  • 金额:
    $ 71.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-15 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Lewy Body Dementia (LBD) is the second most common form of degenerative dementia, affecting at least 2.4 million people in the US, and the overwhelming majority of persons living with LBD (PLBD) are cared for by family caregivers. LBD caregiver strain: 1) exceeds that of non-LBD dementia caregivers; 2) worsens caregiver physical and mental health; and 3) independently increases the risk of PLBD hospitalization and institutionalization. LBD progression is complicated by the synergistic effects of motor, cognitive, and neuropsychiatric decline, and is punctuated by falls, infections, dehydration, and neuropsychiatric symptoms leading to acute healthcare utilization. Although family caregivers are uniquely positioned to identify and manage these challenges, which may avert emergency department visits and reduce morbidity, many caregivers lack the knowledge, skills, confidence, resources, and support to do so. NIA recognizes the gap in enhancing the knowledge and skills of dementia caregivers and the critical need to understand optimal intervention structure, content, mechanisms, and delivery methods for caregiver interventions. Building on our team’s recruitment successes and prior work impacting caregiver strain and PLBD quality of life, the proposed study addresses these gaps using our successfully piloted, peer mentor-delivered educational intervention for LBD caregivers (PERSEVERE). The study aims to 1) quantify the impact of PERSEVERE on caregiver knowledge, attitudes, mastery, and strain; 2) identify the intervention and mentor factors determining implementation fidelity; and 3) test the effects of PERSEVERE on PLBD quality of life and healthcare utilization. These aims will be accomplished in an NIH Behavioral Model Stage II (efficacy) national, randomized, attention-controlled, 12-week trial of PERSEVERE in 502 LBD caregivers in partnership with the Lewy Body Dementia Association, Parkinson’s Foundation, Davis Phinney Foundation, and LBD Caregiver Advisors. We will match caregivers in the intervention arm with a trained peer mentor who will coach them through a modular, practical, theory-based curriculum covering LBD knowledge and social support topics. Caregivers in the attention control condition will receive weekly, curated links to educational materials only. We will identify immediate and delayed intervention effects, including mediators of caregiver strain at twelve weeks, and caregiver strain and PLBD outcomes at nine months. PLBD healthcare utilization and implementation fidelity will be assessed biweekly. Focus groups with mentors and interviews with mentees will further define the intervention- and mentor-specific factors predicting fidelity, mentee outcomes, and retention. Remote recruitment, mentoring, and assessments incorporate community engagement strategies to ensure maximum accessibility and inclusion of underrepresented caregiver groups. Study results will illuminate the extent to which leveraging prior LBD caregivers as expert interventionists can improve current caregiver outcomes, and in turn, PLBD outcomes. These results will inform future adaptation and dissemination of this model for other dementia caregivers.
项目概要/摘要 路易体痴呆 (LBD) 是退行性痴呆的第二常见形式,影响至少 2.4 美国有 100 万人,绝大多数患有 LBD (PLBD) 的人都由 家庭照顾者。 LBD 护理人员应变: 1) 超过非 LBD 痴呆护理人员; 2) 使护理人员的情况恶化 身心健康; 3) 单独增加 PLBD 住院风险 制度化。 LBD 的进展因运动、认知和运动的协同作用而变得复杂。 神经精神衰退,并伴有跌倒、感染、脱水和神经精神症状 导致急性医疗保健利用。尽管家庭照顾者在识别和管理方面具有独特的地位 这些挑战可能会避免急诊室就诊并降低发病率,但许多护理人员缺乏 实现这一目标的知识、技能、信心、资源和支持。 NIA 认识到在加强 痴呆症护理人员的知识和技能以及了解最佳干预结构的迫切需要, 护理人员干预的内容、机制和实施方法。以我们团队的招聘为基础 拟议的研究解决了影响护理人员压力和 PLBD 生活质量的成功和先前的工作 通过我们成功试点的、同伴导师为小黑裙护理人员提供的教育干预措施来弥补这些差距 (坚持)。该研究旨在 1) 量化 PERSEVERE 对护理人员知识、态度、 掌握和应变; 2)确定决定实施保真度的干预和指导因素;和 3) 测试 PERSEVERE 对 PLBD 生活质量和医疗保健利用率的影响。这些目标将是 在 NIH 行为模型第二阶段(功效)国家、随机、注意力控制、为期 12 周的研究中取得了成就 与路易体痴呆协会合作,在 502 名 LBD 护理人员中进行了 PERSEVERE 试验, 帕金森氏症基金会、戴维斯·芬尼基金会和 LBD 护理顾问。我们将匹配护理人员 干预部门配有训练有素的同伴导师,他们将通过模块化、实用、基于理论的方式指导他们 课程涵盖LBD知识和社会支持主题。处于注意力控制状态的护理人员会 仅接收每周精选的教育材料链接。我们将确定立即和延迟干预 影响,包括十二周时照顾者紧张的中介因素,以及九周时照顾者紧张和 PLBD 结果 几个月。 PLBD 医疗保健利用和实施保真度将每两周评估一次。焦点小组与 导师和对受训者的访谈将进一步确定干预措施和导师的具体预测因素 忠诚度、学员成果和保留率。远程招聘、指导和评估包括 社区参与战略,以确保最大限度地接触和包容代表性不足的护理人员 组。研究结果将阐明在多大程度上利用以前的 LBD 护理人员作为专家干预专家 可以改善当前护理人员的结果,进而改善 PLBD 的结果。这些结果将为未来的适应提供信息 并向其他痴呆症护理人员传播该模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jori Erin Fleisher其他文献

Jori Erin Fleisher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jori Erin Fleisher', 18)}}的其他基金

Reaching the Most Vulnerable: A Novel Model of Care in Advanced Parkinson's Disease
帮助最弱势群体:晚期帕金森病的新型护理模式
  • 批准号:
    10226958
  • 财政年份:
    2017
  • 资助金额:
    $ 71.57万
  • 项目类别:
Reaching the Most Vulnerable: A Novel Model of Care in Advanced Parkinson's Disease
帮助最弱势群体:晚期帕金森病的新型护理模式
  • 批准号:
    9975949
  • 财政年份:
    2017
  • 资助金额:
    $ 71.57万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 71.57万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了